Common-Size Income Statement
Quarterly Data
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The financial performance exhibits a period of significant margin volatility, characterized by a sharp contraction in gross profitability during 2023 and early 2024, followed by a consistent recovery phase through 2026. This cycle is mirrored in the operating income and net income figures, which experienced substantial troughs before returning to historical norms.
- Gross Profitability and Cost of Sales
- A stable cost of sales profile, ranging between 24% and 27% of product sales from 2021 to mid-2022, shifted abruptly starting in late 2023. Cost of sales peaked at 44.96% in March 2024, leading to a corresponding decline in gross profit from approximately 73% to a low of 55.04% in the same period. A steady recovery trend is observed thereafter, with cost of sales decreasing to 28.21% and gross profit returning to 71.79% by September 2026.
- Operating Expenditure Trends
- Research and development expenses remained relatively consistent, generally fluctuating between 16% and 23% of product sales, though a slight upward trend is noted toward the end of 2025. Selling, general, and administrative expenses showed more variance, peaking at 29.03% in December 2023 before entering a sustained downward trajectory, reaching a period low of 17.00% by September 2026, suggesting improved operational efficiency over time.
- Operating Income and Bottom-Line Performance
- Operating income experienced significant volatility, dropping from highs above 40% in 2022 to a low of 13.92% in March 2024. This decline aligns with the peak in cost of sales and SG&A expenses. However, a robust recovery is evident from 2024 onward, with operating income climbing back to 37.54% by the end of the analyzed period. Net income followed a similar pattern, including a notable net loss of 1.59% in March 2024, before rebounding to a peak of 39.10% in September 2026.
- Non-Operating Items and Tax Impact
- Interest expenses increased from approximately 5% of product sales in 2021 to peak levels around 11% in 2023, eventually stabilizing between 6% and 8%. The "Other income (expense), net" line item introduced extreme volatility to the pre-tax income, with substantial positive spikes observed in March 2023 (35.31%), September 2024 (22.45%), and September 2025 (22.76%), indicating the presence of significant non-operational gains that frequently offset operating pressures.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?